The rise of #medetomidine as an adulterant in the fentanyl supply necessitates a change in the way overdoses and withdrawal symptoms are addressed.
On Friday, we talked about what providers should know about medetomidine and how best to adapt care.
https://t.co/HeQeGHvgyp
Xylazine is being found less and less in the local drug supply, and another sedative, medetomidine, is taking its place.
@CooperHealthNJ's Joseph D'Orazio, MD, explains what that means for health care providers.
https://t.co/wLtWQ6p5kc
#addictionmedicine
📖NEW GUIDE:
Medications for opioid use disorder are the standard of treatment for patients with OUD diagnoses.
This guide explains various MOUD options and what factors to consider when starting MOUD.
#addictionmedicine
https://t.co/nc6gGdr97N
Coming up on Dec. 5:
Medetomidine is increasingly taking over xylazine as an adulterant in the local supply of fentanyl.
Learn more about both adulterants in this free lecture offering CME credits.
https://t.co/rpRIjx7ZQ9
Medetomidine is quickly replacing xylazine as an adulterant in the Philadelphia drug supply.
Review the below guide for managing medetomidine exposure.
https://t.co/1D3mUHWStW
#xylazine#medetomidine
📆THIS FRIDAY:
Join SNJMATCOE experts to learn more about methadone and its important role as a medication for opioid use disorder (or MOUD).
Free CMEs are available for those who register and attend this virtual lecture.
#addictionmedicine#freecme
https://t.co/rpRIjx8xFH
📅Less than one week until our day-long Office-Based Addiction Care lecture series!
Attending physicians are eligible for up to 8 AOA category 1-A CME credits, or 8 AMA PRA Category 1 CME credits.
Sign up here:
https://t.co/rpRIjx7ZQ9
📅 LECTURE RESCHEDULED:
Our Bupe in OBAT Setting lecture has been rescheduled to September 26 from 11 a.m. until 1 p.m.
Free CMEs are available. #addictionmedicine
https://t.co/rpRIjx7ZQ9
📅Join us Sept 2 for lectures covering everything Office-Based Addiction Treatment.
Discover how NJ's OBAT program expands access to medications for addiction treatment services by supporting primary care offices.
https://t.co/rpRIjx8xFH
Miss an educational lecture?
We recently launched an archive of our presentations covering a wide range of addiction medicine topics.
https://t.co/gVYcE4MCQi
Patient navigators stationed in the Emergency Department can help patients find treatment and knock down any barriers to that care.
Learn more about the unique role patient navigators play in the ED in this Q&A.
https://t.co/H4A259h1He
TOMORROW:
📕Join us at 11 a.m. on Friday, July 25 to learn about the intersection of mental health and substance use disorders.
CMEs are available for this free lecture.
Sign up: https://t.co/hfiO6Z5BEJ
In our presentation archive, you'll find educational lectures covering topics such as:
• Addiction Med in Primary Care
• Xylazine Contamination in the Drug Supply
• Caring for Substance Exposed Infants
• Urine Toxicology Interpretation
and more. 📔
https://t.co/HmTxmhw2y8
Addiction experts will cover:
• Neurobiology of Addiction
• SUD as a Chronic Medical Disease
• Special Populations (Pregnancy & Adolescents)
• Pain Control
• Harm Reduction
• Overdose Crisis; Trends and Statistics
• Clinical Cases and Q&A session
And more...
Join us this month for a virtual training on hospital-based addiction care. Free CME credits available for this full-day event.
📆July 29 from 9am-5pm
Sign up here:
https://t.co/rpRIjx7ZQ9
When should you use urine drug screens? And exactly what can you learn from the results?
On June 27, SNJMATCOE experts will explain these tests and how to best utilize them in practice.
Register for this free lecture below:
https://t.co/rpRIjx8xFH
📣 New Lectures📣
The SNJMATCOE is hosting lectures through the summer about urine drug test interpretations, methadone, bupe in an OBAT setting, and the intersection of mental health disorders and addiction. Free CME credits are available.
🗓️Schedule: https://t.co/rpRIjx7ZQ9
And our research team presented posters detailing the use of buprenorphine by EMS teams responding to overdose calls and examining the experience of "leave behind naloxone" in the community.
Dr. Jennifer Moyer, trained in both addiction medicine and geriatrics, presented to a packed room what she's learned about treating addiction in older adults.
These patients often have unique health concerns and Dr. Moyer has found success in using a group model.
Dr. Joseph D'Orazio also led a panel which educated the audience on our most current understanding of how to best treat xylazine-associated wounds, including harm reduction methods and surgical techniques.